机构:[1]School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Guangzhou 510006, China深圳医学信息中心中国医学科学院阜外医院深圳医院[2]School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China[3]Department of Pharmacy, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen 518107, China深圳市康宁医院深圳医学信息中心中国医学科学院阜外医院深圳医院[4]School of Chinese Materia Medica, Guangzhou University of Chinese Medicine, Guangzhou 510006, China深圳市中医院深圳医学信息中心[5]Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Guangzhou 510006, China
Intestinal flora imbalance is one of the potential pathogenesis of inflammatory bowel diseases, and the study aims to discover the effect of berberine on the composition and function of gut microbiota in ulcerative colitis (UC) rats. UC rats were induced by dextran sulfate sodium (DSS) and administrated with berberine. Colonic morphological changes and claudin-1 protein of colon tissues were primarily examined to validate the protective effects brought by berberine treatment. Then the composition and function of gut microbiota were analyzed, accompanied with quantitative analysis of serum amino acids. The results showed that berberine could not only ameliorate the colonic damages in DSS-induced UC rats but also regulate the gut microbiota by increasing lactic acid-producing bacteria and carbohydrate hydrolysis bacteria as well as decreasing conditional pathogenic bacteria. Accordingly, the relevant functions of above bacteria were improved, including the metabolism and biosynthesis of amino acids, capability of DNA replication and repair, carbohydrate digestion and absorption and glycolysis/gluconeogenesis. Furthermore, the serum amino acids were regulated and showed high correlation with the gut microbiota after berberine treatment. In conclusion, the study confirms the effect of berberine on ameliorating the colonic damage and highlights some specific bacteria and relevant functions linked with berberine treatment, exploring the potential of gut microbiota as a diagnostic biomarker or a therapeutic target in UC treatment.
基金:
the National Natural
Science Foundation of China (No. U1803123), the Key Projects of
Guangdong Natural Science Foundation (No. 2017A030311022), the
Zhongshan Science and Technology Program (No. 2016C1015), the
Science Program for Overseas Scholar of Guangzhou University of
Chinese Medicine (Torch Program) (No. XH20170111) and the
Guangdong Provincial Key Laboratory of Construction Foundation
(No. 2017B030314030).
第一作者机构:[1]School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Guangzhou 510006, China[2]School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China[3]Department of Pharmacy, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen 518107, China
通讯作者:
通讯机构:[1]School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Guangzhou 510006, China[2]School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China[5]Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Guangzhou 510006, China
推荐引用方式(GB/T 7714):
Liao Ziqiong,Xie Yuzhen,Zhou Benjie,et al.Berberine ameliorates colonic damage accompanied with the modulation of dysfunctional bacteria and functions in ulcerative colitis rats.[J].APPLIED MICROBIOLOGY AND BIOTECHNOLOGY.2020,104(4):1737-1749.doi:10.1007/s00253-019-10307-1.
APA:
Liao Ziqiong,Xie Yuzhen,Zhou Benjie,Zou Baorong,Xiao Dan...&Xie Zhiyong.(2020).Berberine ameliorates colonic damage accompanied with the modulation of dysfunctional bacteria and functions in ulcerative colitis rats..APPLIED MICROBIOLOGY AND BIOTECHNOLOGY,104,(4)
MLA:
Liao Ziqiong,et al."Berberine ameliorates colonic damage accompanied with the modulation of dysfunctional bacteria and functions in ulcerative colitis rats.".APPLIED MICROBIOLOGY AND BIOTECHNOLOGY 104..4(2020):1737-1749